rs794728934
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_000335.5(SCN5A):c.4296+6T>C variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00000342 in 1,461,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000335.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.4299+6T>C | splice_region_variant, intron_variant | ENST00000413689.6 | NP_001092874.1 | |||
SCN5A | NM_000335.5 | c.4296+6T>C | splice_region_variant, intron_variant | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.4299+6T>C | splice_region_variant, intron_variant | 5 | NM_001099404.2 | ENSP00000410257.1 | ||||
SCN5A | ENST00000423572.7 | c.4296+6T>C | splice_region_variant, intron_variant | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461380Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726992
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with SCN5A-related conditions. ClinVar contains an entry for this variant (Variation ID: 201588). This variant is not present in population databases (ExAC no frequency). This sequence change falls in intron 24 of the SCN5A gene. It does not directly change the encoded amino acid sequence of the SCN5A protein, but it affects a nucleotide within the consensus splice site of the intron. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2012 | c.4299+6 T>C: c.4299+6 T>C:IVS24+6 T>C in intron 24 of the SCN5A gene (NM_198056.2) Although the IVS24+6 T>C mutation in the SCN5A gene has not been reported previously to our knowledge, the mutation destroys the splice donor site of intron 24 and is expected to cause abnormal gene splicing. IVS24+6 T>C is predicted by several splice site prediction algorithms to destroy the splice-donor site of intron 24 leading to abnormal gene splicing. The mutation is predicted to lead to either an abnormal message, which is subjected to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. Therefore, IVS24+6 T>C in the SCN5A gene is interpreted as a disease-causing mutation. The variant is found in BRUGADA,LQT panel(s). - |
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jun 06, 2022 | This variant causes a T to C nucleotide substitution at the +6 position of intron 24 of the SCN5A gene. Splice prediction tools are inconclusive regarding the impact of this variant on RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at